Option Chain

Enliven Therapeutics Inc

ELVNNASDAQ · USD

37.32USD0.00 (-5.12%)

3110

Enliven Therapeutics Inc (ELVN) Option Chain

As of October 16, 2026, Enliven Therapeutics Inc is trading at $37.32, a -5.12% change from the previous close. The nearest expiration is Nov 20, 2026. Implied volatility is 61.4%. IV Rank is 18%.

Tracking the ELVN option chain helps you see every strike and expiry on Enliven Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Enliven Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ELVN options activity at a glance. Use our scanner to monitor the ELVN option chain in real time and filter for the ELVN options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ELVN stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ELVN option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ELVN stock options are being actively traded and where they are not.

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Enliven Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ELVN options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ELVN stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile51.19% Neutral
Market cap (M$)2,734
52 weeks high-40.12%
52 weeks low152.50%
Analyst recommendationStrong Buy
1.13
Target price$73.31
96.44% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-11
P/E—
Future P/E—
EPS (ttm)-1.67
EPS growth next 5 years-15.63%

As of October 16, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
14.03	0	0	0.73	7.32	6.10	10.00	30.00	-19.61	—	2.40	0.00	2.40	0	0	85.97
39.56	0	0	1.96	2.32	2.55	6.00	35.00	-6.22	—	2.40	0.00	2.40	0	1	60.44
67.02	0	0	1.93	0.00	0.15	3.70	40.00	+7.18	2.35	6.10	2.68	1.55	0	6	32.98
85.60	0	0	2.45	0.00	—	2.45	45.00	+20.58	6.20	10.00	7.68	0.42	0	30	14.40
94.72	0	0	2.15	0.00	—	2.15	50.00	+33.98	10.60	14.70	12.68	-0.03	0	0	5.28

As of October 16, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place